Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation

BackgroundThe conventional treatment protocol in high-intensity focused ultrasound (HIFU) therapy utilizes a dense-scan strategy to produce closely packed thermal lesions aiming at eradicating as much tumor mass as possible. However, this strategy is not most effective in terms of inducing a systemic anti-tumor immunity so that it cannot provide efficient micro-metastatic control and long-term tumor resistance. We have previously provided evidence that HIFU may enhance systemic anti-tumor immunity by in situ activation of dendritic cells (DCs) inside HIFU-treated tumor tissue. The present study was conducted to test the feasibility of a sparse-scan strategy to boost HIFU-induced anti-tumor immune response by more effectively promoting DC maturation.MethodsAn experimental HIFU system was set up to perform tumor ablation experiments in subcutaneous implanted MC-38 and B16 tumor with dense- or sparse-scan strategy to produce closely-packed or separated thermal lesions. DCs infiltration into HIFU-treated tumor tissues was detected by immunohistochemistry and flow cytometry. DCs maturation was evaluated by IL-12/IL-10 production and CD80/CD86 expression after co-culture with tumor cells treated with different HIFU. HIFU-induced anti-tumor immune response was evaluated by detecting growth-retarding effects on distant re-challenged tumor and tumor-specific IFN-γ-secreting cells in HIFU-treated mice.ResultsHIFU exposure raised temperature up to 80 degrees centigrade at beam focus within 4 s in experimental tumors and led to formation of a well-defined thermal lesion. The infiltrated DCs were recruited to the periphery of lesion, where the peak temperature was only 55 degrees centigrade during HIFU exposure. Tumor cells heated to 55 degrees centigrade in 4-s HIFU exposure were more effective to stimulate co-cultured DCs to mature. Sparse-scan HIFU, which can reserve 55 degrees-heated tumor cells surrounding the separated lesions, elicited an enhanced anti-tumor immune response than dense-scan HIFU, while their suppressive effects on the treated primary tumor were maintained at the same level. Flow cytometry analysis showed that sparse-scan HIFU was more effective than dense-scan HIFU in enhancing DC infiltration into tumor tissues and promoting their maturation in situ.ConclusionOptimizing scan strategy is a feasible way to boost HIFU-induced anti-tumor immunity by more effectively promoting DC maturation.

[1]  H. Fujii,et al.  Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines , 2004, Cancer Immunology, Immunotherapy.

[2]  F. Gleeson,et al.  High-intensity focused ultrasound for the treatment of liver tumours. , 2004, Ultrasonics.

[3]  Wen-zhi Chen,et al.  Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. , 2004, Ultrasound in medicine & biology.

[4]  Feng Wu,et al.  Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. , 2008, Ultrasound in medicine & biology.

[5]  Wen-Zhi Chen,et al.  Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. , 2010, European journal of radiology.

[6]  O. Eremin,et al.  Dendritic cells are dysfunctional in patients with operable breast cancer , 2004, Cancer Immunology, Immunotherapy.

[7]  L. French,et al.  Tumor-Infiltrating Dendritic Cells Are Potent Antigen-Presenting Cells Able to Activate T Cells and Mediate Tumor Rejection1 , 2006, The Journal of Immunology.

[8]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[9]  Wen-zhi Chen,et al.  [High intensity focused ultrasound in the treatment of primary malignant bone tumor]. , 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[10]  G. Trinchieri,et al.  Interleukin‐10 in viral diseases and cancer: exiting the labyrinth? , 2004, Immunological reviews.

[11]  F A Jolesz,et al.  MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. , 2001, Radiology.

[12]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[13]  G. Kramer,et al.  Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T‐cells , 2004, The Prostate.

[14]  Yunbo Liu,et al.  Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. , 2005, Biochemical and biophysical research communications.

[15]  C. Chaussy,et al.  The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection , 2003, Current urology reports.

[16]  D. Carbone,et al.  Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. , 1996, Cellular immunology.

[17]  C R Hill,et al.  Lesion development in focused ultrasound surgery: a general model. , 1994, Ultrasound in medicine & biology.

[18]  A. Horwich,et al.  Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[19]  J. J. de la Rosette,et al.  Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate , 2000, Journal of clinical pathology.

[20]  Pei Zhong,et al.  Investigation of HIFU-induced anti-tumor immunity in a murine tumor model , 2007, Journal of Translational Medicine.

[21]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[22]  Wen-zhi Chen,et al.  Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. , 2004, Ultrasound in medicine & biology.

[23]  L. Zitvogel,et al.  Molecular characteristics of immunogenic cancer cell death , 2008, Cell Death and Differentiation.

[24]  J. Hwang,et al.  Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. , 2009, JOP : Journal of the pancreas.

[25]  Wen-Zhi Chen,et al.  Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. , 2004, Ultrasonics sonochemistry.

[26]  M. Tsan,et al.  Heat shock proteins and immune system , 2009, Journal of leukocyte biology.

[27]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.